|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 |
| (11) | Patento numeris | 1784426 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05810856.4 |
| Europos patento paraiškos padavimo data | 2005-09-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-05-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-11-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/031401 |
| Data | 2005-09-02 |
| (87) | Numeris | WO 2006/026759 |
| Data | 2006-03-09 |
| (30) | Numeris | Data | Šalis |
| 607377 P | 2004-09-03 | US |
| (72) |
DENNIS, Mark, S., US
FONG, Sherman, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
|
| (54) | HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR |
| HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR |